Funds research and development of decentralized, field-ready diagnostics for rapid pan-Orthoebolavirus outbreak detection and containment in resource-limited, high-risk regions.
Funder: Infectious Diseases Society of America
Due Dates: Rolling (applications reviewed as received; proposals may be selected before deadline)
Funding Amounts: Up to 12 awards; typical budgets per project: $150,000–$800,000 USD; durations range 18–36 months depending on opportunity.
Summary: Supports field-ready innovations in decentralized pan-Orthoebolavirus diagnostics, aiming for rapid outbreak detection and containment in resource-limited, high-risk settings.
Key Information: Strong preference for applicants/partners in DRC, Uganda, or EVD-endemic countries; BSL-4 access and outbreak specimen partnerships required for some tracks.
This grant aims to accelerate the development and deployment of innovative, field-ready diagnostic tools and quality systems for pan-Orthoebolavirus (including Bundibugyo virus) in response to critical gaps revealed by the 2026 Ebola outbreak. The initiative funds projects to advance biomarker discovery, specimen validation, diagnostic product development, surveillance and early warning systems, and quality assurance infrastructure. Solutions must be designed for rapid, decentralized use in resource-limited, high-risk regions, eliminating dependence on laboratory infrastructure, cold chains, or highly specialized training. Projects should demonstrate technical rigor, context-appropriate design, and meaningful partnerships with institutions in affected regions, particularly the Democratic Republic of the Congo (DRC), Uganda, or other EVD-endemic countries. The ultimate goal is to enable reliable, rapid, and safe detection and containment of Orthoebolavirus outbreaks at the community level.